Azura Ophthalmics Ltd.
USPTO PatentsView assignee record - 17 granted patents across 5 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Azura ranks #16,612 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 5 technology areas.
- #16,612
- of 49,997 US assignees by volume
- Top 37%
- by Innovation Score (39.8/100)
- 18.1
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R16612 · Foreign Corporation #16,612 · 17 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 17 grants
- MID-PACK #16,612/49,997
- PHOTO-FINISH Ausco Products
- CPC-NARROW A61P · 5 areas
- INNOV-THIN 39.8/100
- CLAIMS-RICH 18.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2020–2025 · 6y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Ausco Products, Inc (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Azura’s 39.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Azura
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Cathay Biotech · near
Cathay Biotech · near
40 score
- Topera · near
Topera · near
40 score
- Twistlock · near
Twistlock · near
40 score
- Azura Ophthalmics · this assignee
Azura Ophthalmics · this assignee
40 score
- CSA Medical · near
CSA Medical · near
40 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Azura's Innovation Score is 39.8/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Azura?
Each dot is one of Azura’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Azura’s own 18.1 claims/patent is ABOVE the 13.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Azura's grants concentrate
Azura Ophthalmics Ltd. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (4 grants) versus a trough of 2 in 2021. By volume, Azura sits between Ausco Products, Inc and BBK Tobacco & Foods, LLP.
Azura's three-year grant acceleration
Azura Ophthalmics Ltd. shows 10 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Azura's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Ausco Products
Ausco Products, Inc
17 patents
- Autronic Plastics
Autronic Plastics, Inc.
17 patents
- Avi Networks
Avi Networks
17 patents
- Awexome Ray
AweXome Ray, Inc.
17 patents
- Bannack Medical
Bannack Medical LLC
17 patents
- Baselayer Technol…
Baselayer Technology, LLC
17 patents
- Battenfeld-cincin…
Battenfeld-cincinnati Germany GMBH
17 patents
- BBK Tobacco & Foo…
BBK Tobacco & Foods, LLP
17 patents
- Azura Ophthalmics ◀
Azura Ophthalmics Ltd.
17 patents
What this shows Azura holds 17 patents at rank #16,612, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Azura
By rank, the assignees closest to #16,612 in granted patent volume.
- Ausco Products, Inc #16,608 · 17 patents
- Autronic Plastics, Inc. #16,609 · 17 patents
- Avi Networks #16,610 · 17 patents
- AweXome Ray, Inc. #16,611 · 17 patents
- Bannack Medical LLC #16,613 · 17 patents
- Baselayer Technology, LLC #16,614 · 17 patents
- Battenfeld-cincinnati Germany GMBH #16,615 · 17 patents
- BBK Tobacco & Foods, LLP #16,616 · 17 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Azura's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Azura, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Azura ranks #1,155 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (40 here).
Azura's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 4 | 23.5% |
| 2021 | 2 | 11.8% |
| 2022 | 4 | 23.5% |
| 2023 | 3 | 17.6% |
| 2024 | 3 | 17.6% |
| 2025partial year | 1 | 5.9% |
Which technologies does Azura Ophthalmics Ltd. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Azura Ophthalmics Ltd.'s patent record in context - here's where to go next.
- Azura Ophthalmics Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #16,612 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Azura Ophthalmics Ltd. against Ausco Products, Inc, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 39.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.